I-Genetic ne-Environment Yakho ehlangene ne-Trigger MS
Izici zengozi nombuzo othi ubani othola i- multiple sclerosis (MS) kunzima kakhulu. Ngenxa yokuthi abacwaningi abaqondi ngokugcwele izimbangela ze-MS , abaqondi nokuthi kungani abanye abantu bethola i-MS nabanye abakwenzi.
Ithuba lakho lokuthuthukisa i-MS lincane. Eqinisweni, umuntu ojwayelekile wase-US unelinye ithuba elingama-750 lokuthola i-MS. I-National Multiple Sclerosis Society ilinganisa ukuthi abantu abangu-400 000 base-US baye bathola ukuthi bane-MS, kanti abantu abangaba ngu-200 batholakala ukuthi bane-MS e-US ngesonto ngalinye.
Ukulinganiswa kwenani labantu abaphila nge-MS engatholakali kuhlukahluka kakhulu.
Ezweni, izibalo ze-MS kunzima ukuzithola ngoba i-MS yisifo esiyinselele sokuthola. Lokho kuthiwa, cishe abantu abayizigidi ezingu-2,5 emhlabeni bane-MS.
Amanani e-MS e-US ayanda ngonyaka ngamunye. Lokhu kungachazwa izivivinyo ezingcono zokuxilonga (ikakhulukazi ukuhlolwa kwe-MRI ) nokuqwashisa okwengeziwe kwe-MS. Kungenzeka ukuthi amanye amacala amaningi e-MS ayengatholakali ngaphambi kokuba i-MRIs isetshenziswe kabanzi.
Ubulili
Abesifazane banamathuba amabili kuya kathathu ngaphezu kwamadoda okutholakala ukuthi bane-MS, futhi i-MS ibonakala iyanda emvamisa kwabesifazane kunamadoda. Abacwaningi bakholelwa ukuthi umehluko we-hormonal kubantu besilisa nabesifazane ubeka ingozi ephezulu kwabesifazane.
Umlando womndeni
Uma kungenjalo amalungu omndeni wakho ayenayo i-MS, amathuba akho okuba ne-MS anesinye ku-750. Kodwa, uma unezingane ezinama-MS, ingozi yakho ikhuphuka ibe yi-3 kuya kweyesihlanu ku-100.
Uma une-twin efanayo ne-MS, ingozi yakho ingamayelana nanye kwababili noma amane.
Kuyathakazelisa ukuthi amawele afanayo awahlali nawo onke ama-MS, nakuba ahlanganyela ngamaphesenti angu-100 kolwazi lwabo lofuzo. Lokhu kungakho abacwaningi baphetha ngokuthi i-MS ayiyona nje isifo sofuzo.
I-Geography
I-MS iqhubekela phambili kaningi ezindaweni ezikude ukusuka ku-equator (ngenhla kwezingu-40 degrees latitude).
Amanani we-MS kulezi zifunda ezisenyakatho angaba izikhathi ezinhlanu ngaphezulu. Uma umuntu edabula esifundeni esingozi kakhulu endaweni engaphansi kwezinhlekelele ngaphambi kweminyaka engu-15, athatha ingozi ephansi. Abacwaningi bacabanga ukuthi ukukhulelwa (ama-hormone) kanye ne-geography ngandlela-thile kungahlanganyela ukuze kwandiswe ingozi ye-MS.
Kuyathakazelisa ukuphawula ukuthi kunamaqoqo angavamile wezindawo ezinamazinga aphezulu we-MS. Abacwaningi batadisha la maqoqo ukuze bafunde ukuthi yiziphi izimo emvelweni ezingakhuphula ingozi ye-MS . Kuze kube manje, akukho lutho olutholakali.
Ubudala
Iningi le-MS litholakala phakathi kweminyaka engama-20 no-50, nakuba kokubili ubuntwana ne-MS ekupheleni kwesikhathi kungenzeka.
Ukwelashwa kwe-Vitamin D
Amazinga aphezulu e-vitamin D, afana nalawo angaphezu kuka-75ng / mL, abonakala evikela ekuthuthukiseni i-MS, ngokusho kocwaningo olwenziwe nge- Neurology . Ukugcina izinga eliphilile le-vitamin D (esingazi kahle ukuthi yilokho) lingavumela futhi umuntu ukulwa nokuthuthukisa i-MS, lapho ehlongozwayo.
Ukubhema
Olunye ucwaningo lubonisa ukuthi ukubhema kwandisa ingozi yokuthuthukisa i-MS. Lolu xhumano olunembile alukacaci nokuthi yini ngokuqondene nokubhema okwandisa ingozi.
Izwi elivela
Izici eziningi zobungozi be-sclerosis ziyinkimbinkimbi futhi iningi lilokhu lingachazi, nakuba siyazi ukuthi ukukhiqizwa kwezakhi zakho zofuzo kanye nomdlalo wakho wezemvelo kuyingxenye ndawonye.
Lokhu kusho ukuthi abanye abantu mhlawumbe bahlaselwa yi-gene ngokwemvelo ekuthuthukiseni i-MS, kodwa ngemuva kokuba ukuvezwa kokuthile emvelweni kuthatha ukuthi lokho okushiwo yizo zofuzo kufezeka.
Imithombo:
I-Ascherio A & Munger KL. (2007). Izimo ezingozini zemvelo ze-multiple sclerosis. Ingxenye II: Izinto ezingezona ezithathelwanayo. Ama-Annal of Neurology, uJuni; 61 (6): 504-13.
I-National Institute of Neurological Disorders and Stroke. I-Multiple Sclerosis: Ithemba Ngokucwaninga.
> National MS Society. Yini eyenza i-MS?
USalzer J et al. (2012). I-Vitamin D iyinto evikelayo ekufweni kwe-multiple sclerosis. Neurology, Nov 20; 79 (12): 2140-5.